ESC 365 - Triple oral combination – Who can benefit.

Open Access

Triple oral combination – Who can benefit.

Session: Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2)

Topic: Chronic pulmonary hypertension

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Sponsored by Actelion Pharmaceuticals Ltd

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)

5 presentations

0 follower

3 more presentations in this session

Introduction - Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2).

Speaker: Professor S. Rosenkranz (Cologne, DE)

Intravenous therapy and transplantation – When to start.

Speaker: Professor M. Humbert (Le Kremlin-Bicetre, FR)

Panel discussion - Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2).

Speaker: Professor N. Galie (Bologna, IT)

Access the full session

Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 2)

Speakers: Professor V. McLaughlin, Professor S. Rosenkranz, Professor M. Humbert, Professor N. Galie

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources